Germany· DE-A57-8da1c226cf629efd
Vitalipid Infant
A medicinal product containing retinol palmitate, ergocalciferol, phytomenadione, dl-alpha-tocopherol, registered in Germany by Baxter Deutschland Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Retinol Palmitate, Ergocalciferol, Phytomenadione, Dl-Alpha-Tocopherol
- Manufacturer
- Baxter Deutschland Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- July 8, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Retinol palmitate, ergocalciferol, phytomenadione, dl-alpha-tocopherol in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2578efdd-42e7-427d-b0a1-cc54d54d0761 GET /v1/drugs/2578efdd-42e7-427d-b0a1-cc54d54d0761?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Retinol Palmitate, Ergocalciferol, Phytomenadione, Dl-Alpha-Tocopherol",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about retinol palmitate, ergocalciferol, phytomenadione, dl-alpha-tocopherol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.